Plus Therapeutics, Inc. (PSTV) Discusses Business Update, REYOBIQ Clinical Program Progress, and Recent Financial Offering Transcript

Core Insights - The company provided a business update regarding its REYOBIQ clinical program and CNSide U.S. commercialization [2][3] Company Developments - The latest corporate presentation was filed with the SEC in an 8-K filing and is available on the company's website [3] - The conference call included participation from the CEO and CFO, indicating a focus on future performance and operational results [3] Communication and Transparency - The company emphasized the availability of its press release and corporate presentation on its website for investor access [2][3]